{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:12:58Z","timestamp":1771668778687,"version":"3.50.1"},"reference-count":61,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,11,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Sickle cell trait (SCT) is unique among the carrier states that are identified during newborn screening. Unlike other heterozygous states for rare recessive diseases, SCT is exceedingly prevalent throughout regions of the world, making sickle cell disease one of the most common monogenetic diseases worldwide. Because of this high frequency, reproductive counseling is of paramount importance. In addition, unlike other carrier states, SCT seems to be a risk factor for several clinical complications, such as extreme exertional injury, chronic kidney disease, and venous thromboembolism. Increasing knowledge about these clinical outcomes can help inform genetic counseling recommendations. Expanding research and clinical efforts are needed to ensure that the promises of modern and precision medicine can be delivered to the millions of SCT carriers and their children.<\/jats:p>","DOI":"10.1182\/asheducation-2018.1.474","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T18:13:59Z","timestamp":1555438439000},"page":"474-481","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":15,"title":["The current state of sickle cell trait: implications for reproductive and genetic counseling"],"prefix":"10.1182","volume":"2018","author":[{"given":"Lydia H.","family":"Pecker","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Pediatrics, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakhi P.","family":"Naik","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111521260625300_B1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1182\/asheducation-2015.1.160","article-title":"Sickle cell trait diagnosis: clinical and social implications","volume":"2015","author":"Naik","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2019111521260625300_B2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/asheducation-2010.1.418","article-title":"Sickle-cell trait: novel clinical significance","volume":"2010","author":"Key","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"2019111521260625300_B3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1473-3099(12)70055-5","article-title":"Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis","volume":"12","author":"Taylor","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"2019111521260625300_B4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.semperi.2009.12.006","article-title":"History and current status of newborn screening for hemoglobinopathies","volume":"34","author":"Benson","year":"2010","journal-title":"Semin Perinatol"},{"issue":"7","key":"2019111521260625300_B5","first-page":"648","article-title":"Evaluation of newborn sickle cell screening programme in England: 2010-2016","volume":"103","author":"Streetly","year":"2018","journal-title":"Arch Dis Child"},{"issue":"2","key":"2019111521260625300_B6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ejhg.2015.104","article-title":"A qualitative study to explore how professionals in the United Kingdom make decisions to test children for a sickle cell carrier status","volume":"24","author":"Noke","year":"2016","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"2019111521260625300_B7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/bjh.14015","article-title":"Improvement of medical care in a cohort of newborns with sickle-cell disease in north Paris: impact of national guidelines","volume":"173","author":"Couque","year":"2016","journal-title":"Br J Haematol"},{"issue":"5-6","key":"2019111521260625300_B8","first-page":"467","article-title":"Sickle cell disease from Africa to Belgium, from neonatal screening to clinical management","volume":"70","author":"L\u00ea","year":"2010","journal-title":"Med Trop (Mars)"},{"issue":"3","key":"2019111521260625300_B9","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/S2214-109X(15)00288-0","article-title":"Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): a cross-sectional study","volume":"4","author":"Ndeezi","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"4","key":"2019111521260625300_B10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/pbc.25875","article-title":"Newborn screening for sickle cell disease in Liberia: a pilot study","volume":"63","author":"Tubman","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"2019111521260625300_B11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12913-016-1572-6","article-title":"Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis","volume":"16","author":"Kuznik","year":"2016","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"2019111521260625300_B12","doi-asserted-by":"crossref","first-page":"e0147081","DOI":"10.1371\/journal.pone.0147081","article-title":"Neonatal screening and the clinical outcome in children with sickle cell disease in central India","volume":"11","author":"Upadhye","year":"2016","journal-title":"PLoS One"},{"issue":"15","key":"2019111521260625300_B13","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/jama.2014.2157","article-title":"Sickle cell trait--neglected opportunities in the era of genomic medicine","volume":"311","author":"Taylor","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"2019111521260625300_B14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10897-011-9395-4","article-title":"At-risk marriages after compulsory premarital testing and counseling for \u03b2-thalassemia and sickle cell disease in Saudi Arabia, 2005-2006","volume":"21","author":"Alswaidi","year":"2012","journal-title":"J Genet Couns"},{"issue":"2","key":"2019111521260625300_B15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10897-015-9874-0","article-title":"Reproductive health CHOICES for young adults with sickle cell disease or trait: randomized controlled trial outcomes over two years","volume":"25","author":"Gallo","year":"2016","journal-title":"J Genet Couns"},{"issue":"1","key":"2019111521260625300_B16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajmg.c.30160","article-title":"Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states","volume":"148C","author":"Kavanagh","year":"2008","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"2019111521260625300_B17","article-title":"Calling for sickle cell trait research","author":"Lee"},{"issue":"10","key":"2019111521260625300_B18","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/ejhg.2010.90","article-title":"Carrier screening for beta-thalassaemia: a review of international practice","volume":"18","author":"Cousens","year":"2010","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"2019111521260625300_B19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12687-017-0294-8","article-title":"Voluntary premarital screening to prevent sickle cell disease in Jamaica: does it work?","volume":"8","author":"Serjeant","year":"2017","journal-title":"J Community Genet"},{"issue":"1","key":"2019111521260625300_B20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00006250-200701000-00055","article-title":"ACOG Practice Bulletin No. 78: hemoglobinopathies in pregnancy","volume":"109","author":"ACOG Committee on Obstetrics","year":"2007","journal-title":"Obstet Gynecol"},{"key":"2019111521260625300_B21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/1471-2393-14-356","article-title":"Obstetrician-gynecologists\u2019 knowledge of sickle cell disease screening and management","volume":"14","author":"Azonobi","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"issue":"18","key":"2019111521260625300_B22","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.281.18.1701","article-title":"First unaffected pregnancy using preimplantation genetic diagnosis for sickle cell anemia","volume":"281","author":"Xu","year":"1999","journal-title":"JAMA"},{"issue":"9","key":"2019111521260625300_B23","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s10815-016-0750-0","article-title":"Recent advances in preimplantation genetic diagnosis and screening","volume":"33","author":"Lu","year":"2016","journal-title":"J Assist Reprod Genet"},{"issue":"9","key":"2019111521260625300_B24","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMsa1506575","article-title":"Declines in unintended pregnancy in the United States, 2008-2011","volume":"374","author":"Finer","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111521260625300_B25","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.fertnstert.2010.11.026","article-title":"Costs of infertility treatment: results from an 18-month prospective cohort study","volume":"95","author":"Katz","year":"2011","journal-title":"Fertil Steril"},{"issue":"7","key":"2019111521260625300_B26","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/humrep\/dep054","article-title":"Providing preimplantation genetic diagnosis in the United Kingdom, The Netherlands and Germany: a comparative in-depth analysis of health-care access","volume":"24","author":"Aarden","year":"2009","journal-title":"Hum Reprod"},{"issue":"3","key":"2019111521260625300_B27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/14647270903037751","article-title":"Preimplantation genetic diagnosis for the prevention of sickle cell disease: current trends and barriers to uptake in a London teaching hospital","volume":"12","author":"Oyewo","year":"2009","journal-title":"Hum Fertil (Camb)"},{"issue":"8","key":"2019111521260625300_B28","doi-asserted-by":"crossref","first-page":"e27102","DOI":"10.1002\/pbc.27102","article-title":"Views of parents of children with sickle cell disease on pre-implantation genetic diagnosis","volume":"65","author":"Darbari","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2019111521260625300_B29","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1373\/clinchem.2011.178939","article-title":"Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia","volume":"58","author":"Barrett","year":"2012","journal-title":"Clin Chem"},{"issue":"9","key":"2019111521260625300_B30","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pd.1507","article-title":"The influence of faith and religion and the role of religious and community leaders in prenatal decisions for sickle cell disorders and thalassaemia major","volume":"26","author":"Ahmed","year":"2006","journal-title":"Prenat Diagn"},{"issue":"9","key":"2019111521260625300_B31","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/medethics-2013-101392","article-title":"Would you terminate a pregnancy affected by sickle cell disease? Analysis of views of patients in Cameroon","volume":"40","author":"Wonkam","year":"2014","journal-title":"J Med Ethics"},{"issue":"13","key":"2019111521260625300_B32","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM198709243171301","article-title":"Sickle-cell trait as a risk factor for sudden death in physical training","volume":"317","author":"Kark","year":"1987","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111521260625300_B33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bjsports-2011-090896","article-title":"Sickle cell trait associated with a RR of death of 37 times in National Collegiate Athletic Association football athletes: a database with 2 million athlete-years as the denominator","volume":"46","author":"Harmon","year":"2012","journal-title":"Br J Sports Med"},{"issue":"5","key":"2019111521260625300_B34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1056\/NEJMoa1516257","article-title":"Sickle cell trait, rhabdomyolysis, and mortality among U.S. Army soldiers","volume":"375","author":"Nelson","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111521260625300_B35","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/aje\/kwx285","article-title":"Sickle cell trait and heat injury among US Army soldiers","volume":"187","author":"Nelson","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"4","key":"2019111521260625300_B36","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1089\/ham.2014.1034","article-title":"The splenic syndrome in individuals with sickle cell trait","volume":"15","author":"Goodman","year":"2014","journal-title":"High Alt Med Biol"},{"issue":"1","key":"2019111521260625300_B37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1249\/JSR.0b013e3181caa9fa","article-title":"Pearls and pitfalls: exertional sickling","volume":"9","author":"Eichner","year":"2010","journal-title":"Curr Sports Med Rep"},{"issue":"2","key":"2019111521260625300_B38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4085\/1062-6050-52.3.02","article-title":"NCAA football off-season training: unanswered prayers\u2026 a prayer answered","volume":"52","author":"Anderson","year":"2017","journal-title":"J Athl Train"},{"issue":"4","key":"2019111521260625300_B39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4085\/1062-6050-47.4.08","article-title":"The inter-association task force for preventing sudden death in collegiate conditioning sessions: best practices recommendations","volume":"47","author":"Casa","year":"2012","journal-title":"J Athl Train"},{"key":"2019111521260625300_B40","article-title":"NCAA addresses exertional rhabdomyolysis","author":"Sitzler"},{"issue":"20","key":"2019111521260625300_B41","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1001\/jama.2014.15063","article-title":"Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans","volume":"312","author":"Naik","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"2019111521260625300_B42","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2016101086","article-title":"Sickle cell trait and the risk of ESRD in blacks","volume":"28","author":"Naik","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2019111521260625300_B43","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1681\/ASN.2016030357","article-title":"African ancestry-specific alleles and kidney disease risk in Hispanics\/Latinos","volume":"28","author":"Kramer","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2019111521260625300_B44","first-page":"789","article-title":"Effect of oxygen tension and of pH on the sickling and mechanical fragility of erythrocytes from patients with sickle cell anemia and the sickle cell trait","volume":"37","author":"Lange","year":"1951","journal-title":"J Lab Clin Med"},{"key":"2019111521260625300_B45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2018.01.007","article-title":"Progressive glomerular and tubular damage in sickle cell trait and sickle cell anemia mouse models","volume":"197","author":"Saraf","year":"2018","journal-title":"Transl Res"},{"issue":"5","key":"2019111521260625300_B46","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1182\/blood.V68.5.985.985","article-title":"Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene","volume":"68","author":"Steinberg","year":"1986","journal-title":"Blood"},{"issue":"6","key":"2019111521260625300_B47","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1172\/JCI115521","article-title":"Effects of alpha-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait","volume":"88","author":"Gupta","year":"1991","journal-title":"J Clin Invest"},{"issue":"3","key":"2019111521260625300_B48","doi-asserted-by":"crossref","first-page":"e1007293","DOI":"10.1371\/journal.pgen.1007293","article-title":"Common \u03b1-globin variants modify hematologic and other clinical phenotypes in sickle cell trait and disease","volume":"14","author":"Raffield","year":"2018","journal-title":"PLoS Genet"},{"issue":"12","key":"2019111521260625300_B49","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/17474086.2017.1395279","article-title":"The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait","volume":"10","author":"Naik","year":"2017","journal-title":"Expert Rev Hematol"},{"issue":"12","key":"2019111521260625300_B50","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/ki.2011.286","article-title":"Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans","volume":"80","author":"Hicks","year":"2011","journal-title":"Kidney Int"},{"issue":"7","key":"2019111521260625300_B51","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1200\/JOP.2017.020909","article-title":"Renal medullary carcinoma: establishing standards in practice","volume":"13","author":"Beckermann","year":"2017","journal-title":"J Oncol Pract"},{"issue":"10","key":"2019111521260625300_B52","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/pbc.25592","article-title":"Renal medullary carcinoma and sickle cell trait: a systematic review","volume":"62","author":"Alvarez","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"18","key":"2019111521260625300_B53","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM197905033001801","article-title":"Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients","volume":"300","author":"Heller","year":"1979","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111521260625300_B54","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1182\/blood-2006-11-057604","article-title":"Sickle cell trait and the risk of venous thromboembolism among blacks","volume":"110","author":"Austin","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2019111521260625300_B55","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jth.12787","article-title":"Prospective study of sickle cell trait and venous thromboembolism incidence","volume":"13","author":"Folsom","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"12","key":"2019111521260625300_B56","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/jth.12744","article-title":"Venous thromboembolism incidence in the cooperative study of sickle cell disease","volume":"12","author":"Naik","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2019111521260625300_B57","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/bjs.1800680308","article-title":"The PO2 in venous valve pockets: its possible bearing on thrombogenesis","volume":"68","author":"Hamer","year":"1981","journal-title":"Br J Surg"},{"issue":"18","key":"2019111521260625300_B58","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/blood-2016-01-694422","article-title":"Elevated D-dimer levels in African Americans with sickle cell trait","volume":"127","author":"Naik","year":"2016","journal-title":"Blood"},{"issue":"7","key":"2019111521260625300_B59","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamaneurol.2018.0571","article-title":"Association of sickle cell trait with ischemic stroke among African Americans: a meta-analysis","volume":"75","author":"Hyacinth","year":"2018","journal-title":"JAMA Neurol"},{"issue":"6","key":"2019111521260625300_B60","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1182\/blood-2016-07-727719","article-title":"Association among sickle cell trait, fitness, and cardiovascular risk factors in CARDIA","volume":"129","author":"Liem","year":"2017","journal-title":"Blood"},{"issue":"6","key":"2019111521260625300_B61","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1182\/blood-2016-08-705541","article-title":"Sickle cell trait is not associated with an increased risk of heart failure or abnormalities of cardiac structure and function","volume":"129","author":"Bello","year":"2017","journal-title":"Blood"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2018\/1\/474\/1251293\/hem01865.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2018\/1\/474\/1251293\/hem01865.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T23:50:01Z","timestamp":1573861801000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2018\/1\/474\/277553\/The-current-state-of-sickle-cell-trait"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,11,30]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2018.1.474","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]}}}